RADX
Radiopharm·NASDAQ
--
--(--)
--
--(--)
4.84 / 10
Netural
Fund flow assessment shows a good score of 7.37/10, with positive Small, Medium, and Large inflow trends despite overall block and extra-large outflows. Analyst coverage is limited but strongly bullish (Strong Buy at 100%), though historical win rates are only 33.3%. The sentiment score of 4.84/10 is neutral, reflecting a mismatch between rising price and analyst expectations. Overall, liquidity is supportive, but conviction remains moderate.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-16
InstitutionB. Riley Securities
Times predicted3
Historical Win Rate33.3%
What is the market sentiment for RADX?
- RADX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.84/10 (Netural).
